Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.4600 (0.77%) ($8.4600 - $8.4600) on Wed. Mar. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.31% (three month average) | RSI | 19 | Latest Price | $8.4600(0.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -4.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(30%) XLRE(24%) SDY(22%) IBB(21%) VWO(21%) | Factors Impacting BCRX price | BCRX will decline at least -1.655% in a week (0% probabilities). VIXM(-10%) TLT(-9%) UUP(-8%) VXX(-7%) PCY(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.655% (StdDev 3.31%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.14(-148.94%) | Resistance Level | $8.92 | 5 Day Moving Average | $8.32(1.68%) | 10 Day Moving Average | $8.51(-0.59%) | 20 Day Moving Average | $8.92(-5.16%) | To recent high | -28.6% | To recent low | 3.4% | Market Cap | $1.493b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |